3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms
1
Interventions
Trastuzumab
16
pertuzumab
14
Capecitabine
14
Letrozole
12
Docetaxel
12
Cyclophosphamide
12
pyrotinib
11
Paclitaxel
10
Standard of Care
9
Radiotherapy
9
Carboplatin
9
trastuzumab deruxtecan
8
Fulvestrant
8
Drug Therapy
8
sacituzumab govitecan
7
Anastrozole
7
exemestane
6
eribulin
6
dalpiciclib
6
abemaciclib
6
Tamoxifen
6
Epirubicin
6
pembrolizumab
5
palbociclib
5
Neoadjuvant Therapy
5
camrelizumab
4
Surveys and Questionnaires
4
Sentinel Lymph Node Biopsy
4
Magnetic Resonance Spectroscopy
4
Fluorodeoxyglucose F18
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Breast Neoplasms
×
FAPI-46
×
Clear all
NCT06540872
2024-08-06
MI-CISDIR
Universität Münster
Phase 2
Not yet recruiting
30 enrolled